Respironics, a subsidiary of technology giant Philips (NYSE:PHG), recalled some 600 of its Trilogy ventilators.
The recall, over a glitch in the ventilator’s power management board, covers Trilogy models 100, 200, and 202, according to a press release.
The problem with the board can cause ventilation failure, with reduced function of an alarm designed to indicate ventilation failure. The issue could cause adverse health effects or death, according to a press release.
The recall covers 600 devices shipped in the U.S., France, United Kingdom, Hong Kong, India, Italy, Korea, Kuwait, the Netherlands and Singapore between Dec. 31, 2013, and Jan. 30.
It’s the 2nd ventilator recall for Respironics in the past year. In June 2013, the company issued a Class I recall of more than 19,000 V60 ventilators, also over a problem with the device’s power management system.
